Current etf page

ETF Analysis

XLV ETF: Healthcare Holdings, Performance and Sector Exposure

XLV answer

XLV, the Health Care Select Sector SPDR Fund, holds the 64 health care companies in the S&P 500: drugmakers, insurers, device makers and service providers. Its largest positions are LLY (16.8%), JNJ (10.0%), ABBV (7.8%), MRK (5.1%), UNH (4.6%), and the top ten make up 60.4% of the fund. XLV's expense ratio is 0.08%, and over the past year its price return was +17.1%.

Expense ratio
0.08%
Fund size
$46.92B
Holdings
64
Top 10 weight
60.4%
1Y price return
+17.1%
Data as of Nov 20, 2026 · Market close
XLV ETF Analysis Summary

State Street Health Care Select Sector SPDR ETF (XLV) currently has an AIQ Score of 68/100, indicating a bullish setup. Momentum is the strongest factor at 92/100. Value is the weakest current factor at 34/100. Performance, momentum, risk, distribution, and exposure evidence should be read together at the latest market-close snapshot.

Updated Nov 22, 2026 · Market-close data

XLV at a Glance

Crawlable current metrics from the latest market-close ETF snapshot.

MetricCurrent
Price$177.24
AIQ Score68/100
Overall ViewBullish
Technical Analysis ConsensusSell
Fund Size—
Expense Ratio0.08%
Holdings Count64
NAV$177.45
Asset ClassEquity
Primary ExposureHealthcare (100.00%)
IssuerSPDR
DomicileUS
Inception DateDec 16, 1998
Distribution Yield1.36%
Beta0.33
Average Volume12.45M
52-week range$141.97-$192.32
RSI 1441.01
50-Day SMA$176.26
200-Day SMA$160.76
Risk Score68/100
Momentum Score92/100
Value Exposure Score34/100
As of Nov 22, 2026 · Market close

XLV Long-Horizon ETF Performance

Trailing returns, growth of $10,000, drawdown history, and calendar-year returns from available daily closes.

History available
Nov 23, 2021 to Nov 20, 2026
$10,000 became
$13,375.59
Worst drawdown shown
-18.11%
PeriodTotal returnAnnualizedMax drawdownStart date
1Y17.05%17.06%-10.84%Nov 20, 2025
3Y37.36%11.16%-18.11%Nov 20, 2023
5Y33.76%6.00%-18.11%Nov 23, 2021
10Y33.76%6.00%-18.11%Nov 23, 2021

Growth of $10,000

Indexed to the first available close in this history window.

Drawdown History

Peak-to-trough decline from each prior high over the available window.

Calendar-Year Returns

Full-year returns where available, with the current calendar year shown as YTD.

Price-return view based on available daily close history; distributions are not reinvested unless already reflected in the source series.

XLVState Street Health Care Select Sector SPDR ETF

Leader

Strong Relative Position

BullishEdge 9/10
$177.24−$0.22 (−0.12%)

Latest quote

  • Momentum
    92
  • Value
    34
  • Quality
    63
  • Risk resilience
    68
  • Sentiment
    —
algovestiq.comScore data as of Nov 20, 2026

XLV ETF Analysis Summary

State Street Health Care Select Sector SPDR ETF (XLV) currently has an AIQ Score of 68/100, indicating a bullish setup. Momentum is the strongest factor at 92/100. Value is the weakest current factor at 34/100. Performance, exposure, distribution, momentum, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 20, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, XLV has AIQ Score of 68/100 with Momentum base of 92/100 and fading Value at 34/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (92/100) leads while Value (34/100) lags. This cross-factor spread creates entry timing uncertainty.

Sector · -0.12% ETF move · XLV classified in its covered industry.

Current Evidence

BullishXLV is in a bullish AIQ regime; Momentum is the strongest visible factor at 92/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is XLV Bullish or Bearish Right Now?

XLV currently has a bullish overall setup. Momentum is the strongest factor at 92/100, while Value is weakest at 34/100. The current evidence suggests a constructive setup.

Bull Case
  • - Momentum is constructive at 92/100.
  • - Risk Resilience is supportive at 68/100.
  • - Price is +0.68% above its 50-day SMA.
Bear Case
  • - Value is the current constraint at 34/100.
  • - Technical consensus has more sell votes than buy votes (27 vs 16).

Current Consensus

XLV's Technical Analysis Consensus is currently Sell, with 16 buy, 3 neutral, and 27 sell votes. XLV's 14-day RSI is 41.01, which places the ETF in a weaker momentum range. XLV's beta is 0.33, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in XLV?

The largest recent change in XLV is Risk Resilience moving up by 4.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
+0.0
Momentum
-3.0
Quality
+0.0
Risk
+4.0

What Would Change the XLV Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, risk resilience improves, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, distribution or liquidity context deteriorates, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive market-context evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

XLV Decision Framework

Public evidence layers, setup checks, and risk context for State Street Health Care Select Sector SPDR ETF.

State Street Health Care Select Sector SPDR ETF (XLV) ETF Analysis

State Street Health Care Select Sector SPDR ETF has an AIQ Score of 68/100 in a Bullish regime. Momentum is strongest at 92/100. Beta is 0.33, below market sensitivity. Review the supporting etf factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextXLV is in a Bullish AIQ regime with score 68/100.
Signal ConflictThe primary conflict is that momentum leads at 92/100 while value lags at 34/100.
Factor EvidenceMomentum 92/100 · Value 34/100 · Quality 63/100 · Risk 68/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 92/100.

TimingPass

Momentum is 92/100 and RSI (14) is 41.0.

Regime fitPass

XLV is in a Bullish regime at 68/100.

Risk controlPass

Risk factor is 68/100 with beta 0.33 and annual volatility 17.15%.

ConflictWait

Current conflict: momentum leads at 92/100 while value lags at 34/100.

AIQ Score
68/100
Price
$177.24
Beta
0.33
RSI (14)
41

XLV Research Cluster

ETF-specific paths for performance, risk, distributions, market context, data, comparisons, and news.

XLV ETF Analytics

XLV holdings context, yield, risk, valuation exposure, momentum, and AIQ evidence.

Fund size
—
Expense ratio
0.08%
Distribution yield
1.44%
View XLV ETF analytics

XLV Technical Analysis

XLV technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Sell
RSI 14
41.01
Price vs SMA-50
+0.68%
View full XLV technical analysis

XLV ETF Market Context

Track XLV market context, news pressure, trend changes, income events, and current allocation evidence.

AIQ Score
68/100
Momentum
92/100
Primary exposure
Healthcare (100.00%)
View XLV ETF context

XLV Distribution Analysis

XLV distribution yield, annualized distributions, payment history, and income context.

Dividend yield
1.44%
Annual dividend
$2.55
Frequency
—
View XLV distribution history

XLV ETF Data

XLV available fund data, market metrics, technical readings, risk measures, and AIQ evidence.

Issuer
SPDR
Holdings
64
NAV
$177.45
View XLV ETF data

XLV Risk Analysis

XLV volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.33
Risk score
68/100
Average volume
12.45M
View XLV risk analysis

XLV ETF News

XLV ETF news, market tone, recent headlines, and catalyst context.

News items
2
Updated
Nov 21, 2026
Sentiment
—
Read XLV ETF news

XLV vs ETF Peers

Current peer cohort: XLV · LLY · UNH · JNJ · ABBV. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
XLV
Current ETF
68/10034/10092/10068/1000.7517.15%Current
LLY
Eli Lilly
66/10023/10085/10080/1000.7835.41%XLV vs LLY
UNH
UnitedHealth Group
67/10082/10062/10076/1000.2736.60%XLV vs UNH
JNJ
Johnson & Johnson
62/10032/10076/10091/1001.2321.34%XLV vs JNJ
ABBV
AbbVie
66/10027/10088/10084/1000.7525.39%XLV vs ABBV
Pairwise Compare links: LLY · UNH · JNJ · ABBVXLV vs LLYXLV vs UNHXLV vs JNJXLV vs ABBVCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 20, 2026.

How XLV scores against the names it is most often compared with.

About the AIQ Score

Methodology for the current ETF evidence.

As of Nov 22, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of ETF evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a XLV ETF return scenario

Open the return calculator with ETF context while purchase price, shares, dates and fees remain user inputs.

Calculate ETF return

Also for XLV: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

No quarterly financial rows in this snapshot.

Checked Nov 22, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

ETF Analytics Snapshot

Current ETF evidence uses fund profile, cost, size, distribution, momentum, and risk fields.

Price
$177.24
As of Nov 20, 2026
Fund size
—
Expense ratio
0.08%
Distribution yield
1.36%
SPDR ETF evidence

ETF pages use fund-native profile fields for cost, size, liquidity, holdings breadth, NAV, issuer, and launch date.

Review ETF analytics
Holdings
64
NAV
$177.45
Average volume
12.45M
Inception
Dec 16, 1998
Asset class
Equity
Primary exposure
Healthcare (100.00%)
Beta
0.33
Momentum score
92/100

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Bearish
RSI 14
41.01
MACD
2.01

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
68/100
Beta
0.33
Annual volatility
17.15%
Max drawdown
-10.84%

XLV ETF FAQ

What are XLV's top holdings?

XLV's largest positions are LLY (16.8%), JNJ (10.0%), ABBV (7.8%), MRK (5.1%), UNH (4.6%).

What is XLV's expense ratio?

XLV's expense ratio is 0.08% a year.